Mainz Biomed NV

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015000LC2
USD
1.16
-0.01 (-0.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

14.44 k

Shareholding (Dec 2024)

FII

0.10%

Held by 5 FIIs

DII

99.89%

Held by 0 DIIs

Promoter

0.00%

How big is Mainz Biomed NV?

22-Jun-2025

As of Jun 18, Mainz Biomed NV has a market capitalization of 6.03 million, with net sales of 0.89 million and a net profit of -26.29 million over the latest four quarters. Shareholder's funds are 6.05 million, and total assets are 13.24 million.

As of Jun 18, Mainz Biomed NV has a market capitalization of 6.03 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 0.89 million, while the sum of net profit for the same period is -26.29 million.<BR><BR>As of Dec 24, the shareholder's funds amount to 6.05 million, and the total assets are reported at 13.24 million.

Read More

What does Mainz Biomed NV do?

22-Jun-2025

Mainz Biomed NV is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $5 million as of December 2023, with a market cap of $6.03 million. Key financial metrics indicate it is loss-making, with a return on equity of -319.55% and no dividend yield.

Overview: <BR>Mainz Biomed NV operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Dec 2023) <BR>Most recent Net Profit: -5 Million (Quarterly Results - Dec 2023) <BR>Market cap: USD 6.03 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.58 <BR>Return on Equity: -319.55% <BR>Price to Book: 1.00<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Mainz Biomed NV technically bullish or bearish?

25-Jun-2025

As of June 13, 2025, the technical trend has shifted to a bearish stance with weak strength, driven by bearish daily moving averages and Bollinger Bands, while the MACD shows mild bullish divergence and the RSI indicates a lack of momentum.

As of 13 June 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a weak strength. Key indicators driving this include the daily moving averages showing bearish signals, and the weekly and monthly KST and Dow Theory also indicating bearish trends. The Bollinger Bands are bearish on both weekly and monthly time frames, while the MACD is mildly bullish on both weekly and monthly, suggesting some divergence. The RSI shows no signal on both time frames, indicating a lack of momentum. Overall, the technical outlook remains negative, particularly in the short term.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 8 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.58

stock-summary
Return on Equity

-319.55%

stock-summary
Price to Book

1.24

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2023)
Net Profit:
-5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-28.83%
0%
-28.83%
6 Months
-41.41%
0%
-41.41%
1 Year
-82.92%
0%
-82.92%
2 Years
-97.58%
0%
-97.58%
3 Years
-85.13%
0%
-85.13%
4 Years
-99.64%
0%
-99.64%
5 Years
0%
0%
0.0%

Mainz Biomed NV for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.80%
EBIT Growth (5y)
-302.00%
EBIT to Interest (avg)
-16.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.63%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.31
EV to EBIT
-0.22
EV to EBITDA
-0.23
EV to Capital Employed
1.84
EV to Sales
4.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-831.05%
ROE (Latest)
-319.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.01%)

Foreign Institutions

Held by 5 Foreign Institutions (0.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mainz Biomed NV"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 80.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.49% vs 0.38% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.90",
          "val2": "0.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-17.40",
          "val2": "-25.60",
          "chgp": "32.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "0.30",
          "chgp": "266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.30",
          "val2": "0.70",
          "chgp": "-428.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.70",
          "val2": "-26.30",
          "chgp": "17.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20,602.30%",
          "val2": "-29,754.70%",
          "chgp": "915.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.90
0.90
Operating Profit (PBDIT) excl Other Income
-17.40
-25.60
32.03%
Interest
1.10
0.30
266.67%
Exceptional Items
-2.30
0.70
-428.57%
Consolidate Net Profit
-21.70
-26.30
17.49%
Operating Profit Margin (Excl OI)
-20,602.30%
-29,754.70%
915.24%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 80.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 17.49% vs 0.38% in Dec 2023

stock-summaryCompany CV
About Mainz Biomed NV stock-summary
stock-summary
Mainz Biomed NV
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available